Keywords: one-time, tax, benefit, drives, bristol-myers, squibb, 2nd-qtr
One-time tax benefit drives Bristol-Myers Squibb 2nd-qtr profits up 90%
Article | 08 August 2005
US drugmaker Bristol-Myers Squibb saw its second-quarter 2005 net profit from continuing operations rocket 89.5% to $991.0 million, with net earnings up 9% at ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
